phenylalanine has been researched along with 9,10-dimethyl-1,2-benzanthracene in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, YP; Nicholls, DM; Sendecki, W | 1 |
Levij, IS; Rubin, D | 1 |
Blaumann, H; Calzetta, O; Itoiz, ME; Kreimann, EL; Longhino, J; Schwint, AE | 1 |
Batistoni, D; Dagrosa, A; FarÃas, S; Garavaglia, R; Itoiz, ME; Kreimann, EL; Schwint, AE | 1 |
Morisawa, M; Togo, T | 1 |
Batistoni, D; Gonzalez, BN; Heber, EM; Itoiz, ME; Kreimann, EL; Nigg, DW; Rebagliati, RJ; Schwint, AE; Trivillin, VA | 1 |
Aromando, RF; Blaumann, H; Calzetta, O; Heber, EM; Itoiz, ME; Longhino, J; Monti Hughes, A; Nievas, SI; Nigg, DW; Pozzi, E; Schwint, AE; Trivillin, VA | 1 |
Altieri, S; Aromando, RF; Bortolussi, S; Garabalino, MA; Heber, EM; Itoiz, ME; Molinari, AJ; Monti Hughes, A; Portu, AM; Pozzi, EC; Saint Martin, G; Schwint, AE; Thorp, SI; Trivillin, VA | 1 |
8 other study(ies) available for phenylalanine and 9,10-dimethyl-1,2-benzanthracene
Article | Year |
---|---|
Effect of 7,12-dimethylbenz(a)anthracene on the binding of aminoacyl transfer RNA in rat liver.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; DDT; Female; In Vitro Techniques; Liver; Mammary Neoplasms, Experimental; Methionine; Peptide Biosynthesis; Peptide Elongation Factors; Peptide Initiation Factors; Phenylalanine; Rats; Ribosomes; RNA, Transfer, Amino Acyl | 1977 |
Chemical carcinogenesis in the hamster cheek pouch. Influence of inhibitors and inducers of alkaline phosphatase.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkaline Phosphatase; Animals; Benz(a)Anthracenes; Carcinoma, Squamous Cell; Cheek; Cricetinae; Head and Neck Neoplasms; Male; Organophosphorus Compounds; Phenylalanine; Phosphates | 1975 |
Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cheek; Cricetinae; Disease Models, Animal; Mesocricetus; Mouth Neoplasms; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents | 2001 |
The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cheek; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Mesocricetus; Mouth Neoplasms; Phenylalanine; Radiation-Sensitizing Agents; Tissue Distribution | 2001 |
GPI-anchored aminopeptidase is involved in the acrosome reaction in sperm of the mussel mytilusedulis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acrosome Reaction; Aminopeptidases; Animals; Bivalvia; Carcinogens; Coumarins; Enzyme Activation; Female; Genistein; Glycosylphosphatidylinositols; Growth Inhibitors; Leucine; Male; Oocytes; Peptides; Phenylalanine; Phosphorylation; Protease Inhibitors; Protein-Tyrosine Kinases; Spermatozoa; Substrate Specificity; Type C Phospholipases | 2004 |
Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Phenylalanine; Precancerous Conditions | 2006 |
Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cricetinae; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Tissue Distribution | 2009 |
Assessing advantages of sequential boron neutron capture therapy (BNCT) in an oral cancer model with normalized blood vessels.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cricetinae; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Phenylalanine; Precancerous Conditions; Thalidomide | 2015 |